ATE72974T1 - Diltiazem-mikrokugeln, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen mit gesteuerter abgabe. - Google Patents

Diltiazem-mikrokugeln, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen mit gesteuerter abgabe.

Info

Publication number
ATE72974T1
ATE72974T1 AT89401180T AT89401180T ATE72974T1 AT E72974 T1 ATE72974 T1 AT E72974T1 AT 89401180 T AT89401180 T AT 89401180T AT 89401180 T AT89401180 T AT 89401180T AT E72974 T1 ATE72974 T1 AT E72974T1
Authority
AT
Austria
Prior art keywords
membrane
diltiazem
pharmaceutical compositions
core
microspheres
Prior art date
Application number
AT89401180T
Other languages
English (en)
Inventor
Henri Desmolin
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Application granted granted Critical
Publication of ATE72974T1 publication Critical patent/ATE72974T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT89401180T 1988-04-27 1989-04-25 Diltiazem-mikrokugeln, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen mit gesteuerter abgabe. ATE72974T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8805629A FR2630647B1 (fr) 1988-04-27 1988-04-27 Microbilles de diltiazem, leur procede de fabrication et compositions pharmaceutiques a liberation prolongee les contenant
EP89401180A EP0340105B1 (de) 1988-04-27 1989-04-25 Diltiazem-Mikrokugeln, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen mit gesteuerter Abgabe

Publications (1)

Publication Number Publication Date
ATE72974T1 true ATE72974T1 (de) 1992-03-15

Family

ID=9365751

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89401180T ATE72974T1 (de) 1988-04-27 1989-04-25 Diltiazem-mikrokugeln, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen mit gesteuerter abgabe.

Country Status (12)

Country Link
EP (1) EP0340105B1 (de)
JP (1) JPH01313431A (de)
AT (1) ATE72974T1 (de)
AU (1) AU614056B2 (de)
CA (1) CA1336326C (de)
DE (1) DE68900903D1 (de)
ES (1) ES2032125T3 (de)
FR (1) FR2630647B1 (de)
GR (1) GR3003988T3 (de)
MX (1) MX9203020A (de)
NZ (1) NZ228846A (de)
ZA (1) ZA892871B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5288505A (en) * 1991-06-26 1994-02-22 Galephar P.R., Inc., Ltd. Extended release form of diltiazem
GB2258613B (en) * 1991-08-12 1996-01-10 Euro Celtique Sa Pharmaceutical diltiazem formulation
KR100221695B1 (ko) * 1991-08-12 1999-09-15 그린 마틴, 브라이언 쥐 테슬리 약학적 구상 제형
JPH08143450A (ja) * 1994-11-14 1996-06-04 Taiyo Yakuhin Kogyo Kk 徐放化製剤
FR2742660B1 (fr) * 1995-12-22 1998-04-03 Ethypharm Lab Prod Ethiques Nouvelles formes de microgranules a liberation prolongee contenant du diltiazem comme principe actif
EP2174586B1 (de) 2008-10-02 2014-12-10 EyeSense AG Implantierbares Sensorelement

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57120518A (en) * 1981-01-19 1982-07-27 Tanabe Seiyaku Co Ltd Preparation of microcapsule
JPS58116414A (ja) * 1981-12-23 1983-07-11 Yamanouchi Pharmaceut Co Ltd ニカルジピン持続性製剤用球形顆粒およびその製造法
JPS5916821A (ja) * 1982-07-16 1984-01-28 Tanabe Seiyaku Co Ltd 非凝集性マイクロカプセルの製法
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
LU85943A1 (fr) * 1985-06-12 1987-01-13 Galephar Comprimes pharmaceutiques permettant l'administration aisee de pellets, leur preparation et leur utilisation
JPS6232166A (ja) * 1985-08-06 1987-02-12 Mitsui Toatsu Chem Inc 発泡体加工用粘着剤
LU86077A1 (fr) * 1985-09-18 1987-04-02 Pharlyse Sa Nouvelles formes galeniques du verapamil,leur fabrication et medicaments contenant ces nouvelles formes galeniques

Also Published As

Publication number Publication date
JPH01313431A (ja) 1989-12-18
MX9203020A (es) 1992-07-01
GR3003988T3 (de) 1993-03-16
ES2032125T3 (es) 1993-01-01
NZ228846A (en) 1991-06-25
CA1336326C (en) 1995-07-18
EP0340105A1 (de) 1989-11-02
AU3336389A (en) 1989-11-02
AU614056B2 (en) 1991-08-15
DE68900903D1 (de) 1992-04-09
FR2630647A1 (fr) 1989-11-03
EP0340105B1 (de) 1992-03-04
FR2630647B1 (fr) 1991-08-16
ZA892871B (en) 1990-12-28

Similar Documents

Publication Publication Date Title
DE69921941T2 (de) Verfahren zur Herstellung von pharmazeutischen Wirkstoffpartikeln
US5085866A (en) Method of producing zero-order controlled-released devices
AU7452887A (en) Controlled absorption pharmaceutical composition
DE69816951D1 (de) Zubereitung enthaltend Cefaclor oder Cephalexin mit modifizierter Freisetzungsmatrix
AU635021B2 (en) Extended release pharmaceutical formulations
NO169996C (no) Fremgangsmaate ved fremstilling av et farmasoeytisk preparat med kontrollert utskillelse av virkestoff
KR880010759A (ko) 방출 조절성 제제
DE642785T1 (de) Heterodisperse Hydrogelsysteme zur verzögerten Freisetzung unlöslicher Arzneistoffe.
SI9010635A (sl) Postopek za izdelavo transdermalnega terapevtskega sistema s povečanim tokom dejavne snovi
CA2065652A1 (en) Controlled release gastroresistant pharmaceutical formulations for oral administration containing bile acids and their salts
NO881296D0 (no) Fremgangsmaate for fremstilling av farmasoeytisk preparat.
DE3856555D1 (de) Diltiazem-Zusammensetzungen mit kontrollierter Wirkstoffabsorption
EP0662832A1 (de) Oral anzuwendende arzneimitteltzusammensetzungen enthaltend 1,2,5,6-tetrahydro-1-methyl-3-pyridicarboxaldehyd-o-methyl-oxim
DE69901062T2 (de) Multipartikuläre pharmazeutische form mit gesteuerter und gepulster wirkstoffabgabe und verfahren zu deren herstellung
ATE72974T1 (de) Diltiazem-mikrokugeln, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen mit gesteuerter abgabe.
US6994873B2 (en) Multiparticulate formulations of lithium salts for oral administration suitable for once-a-day administration
EP0768882A1 (de) Carbamazepin-arzneiform mit verzögerter wirkstofffreisetzung
ES500670A0 (es) Procedimiento de preparar farmacos con liberacion programada de materia activa.
Silva Evaluation of eudragit (R) RL as matrix for oral controlled release of nifedipine